Latest filing published 04 Aug 2021 for Kiora Pharmaceuticals INC, €131.
Filing timeline
BuySaleInsider track record
Michael P. Manzo: trading record in brief
Michael P. Manzo, listed as senior executive, appears in our data through filings on Kiora Pharmaceuticals Inc shares, published by SEC (Form 4). The record holds 32 filings, for trades running from 1 May 2015 to 3 August 2021.
The open-market record consists of 3 sales worth €4,148, with no purchase. Outside the open market, there are 28 share grants and 1 option exercise.
The newest entry dates from 4 August 2021: a share grant of €131, in Kiora Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael P. Manzo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 65 shares@ US$2.407.7% of flowCommon StockSEC:0001104659-21-100199:0
- 160 shares@ US$3.7029.2% of flowCommon StockSEC:0001104659-21-089446:0
- 155 shares@ US$4.1931.3% of flowCommon StockSEC:0001104659-21-077764:0
- 158 shares@ US$4.1331.8% of flowCommon StockSEC:0001104659-21-061948:0
- 194 shares@ US$4.943.2% of flowCommon StockSEC:0001104659-21-048714:0
- 192 shares@ US$5.463.6% of flowCommon StockSEC:0001104659-21-032764:0
- 990 shares@ US$6.3420.8% of flowCommon StockSEC:0001104659-21-011853:0
- 115 shares@ US$4.851.8% of flowCommon StockSEC:0001104659-21-000932:0
- 91 shares@ US$3.763.9% of flowCommon StockSEC:0001104659-20-133324:0
- 97 shares@ US$3.514.0% of flowCommon StockSEC:0001104659-20-120949:0
- 98 shares@ US$3.884.4% of flowCommon StockSEC:0001104659-20-112302:0
- 97 shares@ US$3.943.9% of flowCommon StockSEC:0001104659-20-102298:0
- 95 shares@ US$4.114.0% of flowCommon StockSEC:0001104659-20-090918:0
- 97 shares@ US$4.825.1% of flowCommon StockSEC:0001104659-20-081225:0
- 94 shares@ US$5.114.8% of flowCommon StockSEC:0001104659-20-069822:0
- 93 shares@ US$5.103.4% of flowCommon StockSEC:0001104659-20-057471:0
- 122 shares@ US$4.974.2% of flowCommon StockSEC:0001104659-20-043262:0
- 130 shares@ US$5.014.3% of flowCommon StockSEC:0001104659-20-031497:0
- 7,500 shares0Common StockSEC:0001104659-20-022843:0
- 109 shares@ US$6.004.4% of flowCommon StockSEC:0001104659-20-011330:0
- 119 shares@ US$9.527.6% of flowCommon StockSEC:0001104659-20-001636:0
- 101 shares@ US$7.465.1% of flowCommon StockSEC:0001104659-19-075131:0
- 108 shares@ US$3.862.8% of flowCommon StockSEC:0001104659-19-061123:0
- 185 shares@ US$3.134.0% of flowCommon StockSEC:0001144204-19-048120:0
- 1,649 shares@ US$0.212.3% of flowCommon StockSEC:0001144204-19-038333:0
25 of 32 declarations